STAR — Strides Pharma Science Balance Sheet
0.000.00%
- IN₹82.50bn
- IN₹97.11bn
- IN₹45.65bn
- 83
- 32
- 98
- 85
Annual balance sheet for Strides Pharma Science, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 2,749 | 1,842 | 3,607 | 2,896 | 1,986 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 12,454 | 18,898 | 15,005 | 14,075 | 15,125 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 28,172 | 33,618 | 32,434 | 29,690 | 30,989 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 14,994 | 15,136 | 13,726 | 9,585 | 9,803 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 70,150 | 69,759 | 66,384 | 58,398 | 60,487 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 27,383 | 34,117 | 29,902 | 28,793 | 25,915 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 42,384 | 46,166 | 44,262 | 37,142 | 34,969 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 27,767 | 23,592 | 22,123 | 21,256 | 25,518 |
| Total Liabilities & Shareholders' Equity | 70,150 | 69,759 | 66,384 | 58,398 | 60,487 |
| Total Common Shares Outstanding |